U.S.A.
Immunocidin® Equine
Immunocidin Equine, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the intratumoral treatment of sarcoid tumors in horses.
Available Presentations: 5 mL vial
Download the product brochure. Check out some treatment results
Immunocidin Equine, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the USDA for the treatment of sarcoid tumors in horses.
Although Immunocidin Equine is administered by intratumoral injection, the response is generalized and untreated sites frequently undergo regression as well.
Why use Immunocidin Equine?
• It has a high post-treatment tumor-free survival rate
• It is well-tolerated by horses, including older animals
• It has minimal side effects
• It is an economical treatment option
• It has an excellent safety profile
Video demonstrating administration technique
For veterinarians to purchase product:
Phone (toll-free): 1-844-663-3349
Email: sales@NovaVive.ca